3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Depression - Drug News - Psychiatry / Psychology -

When one antidepressant doesn’t work, another may

Depression • • Drug News • • Psychiatry / PsychologyApr 24, 08

For people suffering from depression that doesn’t respond to treatment with one type of antidepressant, switching to a different type may be the best treatment, according to a new report.

Relatively new antidepressants such as Prozac and Zoloft, for example, are called selective serotonin reuptake inhibitors or SSRIs. In recent clinical trials, only about a third of depressed patients achieved remission with SSRI treatment, the authors explain, but there is little consensus among psychiatrists about the best treatment for patients when an SSRI doesn’t work.

To look into this, Dr. George I. Papakostas from Harvard Medical School, Boston, and his associates conducted an analysis of four clinical trials that compared a switch to a second SSRI versus a non-SSRI antidepressant for SSRI-resistant major depression.

The pooled data included 1496 patients who had not responded to treatment with one SSRI and were subsequently randomly assigned to treatment with another SSRI or a non-SSRI antidepressant.

Patients randomized to switch to a non-SSRI antidepressant were slightly more likely to experience remission than patients who were switched to a second SSRI, the researchers report in the medical journal Biological Psychiatry.

However, the non-SSRI antidepressants were somewhat less well tolerated than the SSRIs.

The results indicate that current treatments for depression are still less than ideal. “There continues to be a pressing need to introduce new antidepressant medications,” comments Dr. John Krystal, the journal’s editor.

SOURCE: Biological Psychiatry, April 1, 2008.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  UGA ecologist finds another cause of antibiotic resistance
  Anxiety increases the risk of gastrointestinal infection and long-term complications
  New drug for neuroblastoma shows promise in phase I study
  Baclofen shows promise in patients with alcohol-induced liver disease
  How negative stereotyping affects older people
  Findings point to an ‘off switch’ for drug resistance in cancer
  Siblings of children with autism can show signs at 18 months
  Exploring the connection between empathy, neurohormones and aggression
  Stopping statins may benefit terminally ill patients
  Cholesterol drug users may use pills as a license to overeat
  Pfizer lung cancer drug beats chemo for previously untreated patients

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site